The emerging class of GLP-1 agonist medication and GIP dual medications, like tirzepatide, semaglutide, and the newly introduced retatrutide, represent groundbreaking improvements in metabolic control. https://tirzepatide209315.timeblog.net/79668052/retatrutide-a-comparative-review